Position in PFE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,797,825
-$671,191 QoQ
Shares Held
157,717
-0.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#711
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HBK Sorce Advisory LLC holds $60,692,879 across 13 Drug Manufacturers - General names. PFE ranks #6 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
17,310 | $20,762,135 | |
| 2 | JNJ |
Johnson & Johnson
|
44,818 | $11,382,427 | |
| 3 | MRK |
Merck & Co., Inc.
|
54,037 | $6,943,754 | |
| 4 | ABBV |
AbbVie Inc.
|
20,828 | $5,241,157 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
30,439 | $3,845,663 | |
| 6 | PFE |
Pfizer Inc
This page
|
157,717 | $3,797,825 | |
| 7 | AMGN |
Amgen Inc
|
9,769 | $3,537,550 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
40,142 | $2,312,982 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,797,825 | 157,717 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $4,469,016 | 159,153 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,776,309 | 151,659 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $4,098,483 | 160,851 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $3,686,007 | 152,063 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $3,650,581 | 144,064 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $3,001,418 | 113,133 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,048,474 | 139,892 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,792,912 | 135,558 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,511,485 | 126,540 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,459,780 | 120,173 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $4,304,172 | 129,761 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $4,654,361 | 126,891 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $4,521,823 | 110,829 | Shares | Sole | 2023-08-15 | |
| 2022-12-31 | $13,903,564 | 271,342 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $5,235,271 | 119,636 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,137,932 | 78,923 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,491,492 | 125,391 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $8,132,543 | 137,723 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $5,960,497 | 138,584 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,073,755 | 155,101 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $4,728,196 | 130,505 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,725,189 | 128,367 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $4,323,145 | 117,797 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,727,378 | 113,987 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,511,275 | 107,576 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||